VC Funds Starting with E

Evolv Ventures is a venture capital firm based in Chicago, founded in 2018 by Kraft Heinz with a $100 million fund to invest in emerging technologies that are transforming the food industry. The fund is particularly focused on early-stage startups in sectors like food technology, retail technology, consumer products, and digital logistics. Evolv Ventures leverages Kraft Heinz’s extensive network, industry expertise, and resources to support the growth of its portfolio companies, positioning itself as a value-added investor in the food tech space. The firm is led by seasoned venture investor Bill Pescatello, who brings a wealth of experience from previous roles at Lightbank and GE Capital. Notable investments by Evolv Ventures include companies like New Culture, which is developing animal-free dairy products, and Zippin, a startup focused on checkout-free retail technology. By combining financial backing with strategic support, Evolv Ventures aims to drive significant innovation and disruption within the food industry, ultimately aligning with Kraft Heinz’s broader goals of staying at the forefront of food innovation.

Evonik Venture Capital, the corporate venture arm of Evonik Industries, manages a fund size of €400 million and has made over 50 investments since 2012. The firm strategically invests in innovative startups across various growth fields such as Nutrition & Care, Smart Materials, Specialty Additives, and Digitalization, with a strong focus on sustainability and carbon neutrality technologies​. Evonik's portfolio includes startups like Interface Polymers, which develops additives for easier recycling of plastics, and SuperC, a leader in graphene materials for improving lithium-ion batteries. Other notable investments are Allay Therapeutics, which has developed a post-surgery pain relief implant, and Citrine Informatics, an AI-driven platform for materials and chemicals development​. The venture capital unit emphasizes early to growth-stage investments, with typical investment volumes of up to €15 million per portfolio company. They aim to be an active partner, providing strategic, technical, and commercial support, and leveraging their extensive network for the growth of their portfolio companies. Evonik Venture Capital operates globally with offices in Germany, the USA, and China, making them well-positioned to support innovative startups in key regions worldwide.

Equity Venture Partners, known as EVP, is an early-stage venture capital firm founded in 2014 in Sydney, Australia, focused exclusively on B2B software companies in Australia and New Zealand. With five funds under management totaling approximately $300 million in funds under management, EVP has spent over a decade partnering with some of the region's most significant software businesses. The most recent fund of $100 million, launched in December 2022, targets early Series A investments. The firm leads rounds with check sizes of $500,000 to $5 million. EVP has made 40 investments and maintains a sector-agnostic approach within B2B SaaS. Notable portfolio companies include SiteMinder, a hotel technology platform listed on the ASX, Deputy in workforce management software, Ignition in proposal and client engagement software, and Shippit in shipping and logistics technology. The firm was founded by Daniel Szekely, Howard Leibman, Justin Lipman, and Les Szekely, and has grown to a team of 11 to 50 employees over its decade of operation. EVP positions itself as a long-term partner for Australian and New Zealand software founders, providing not only capital but also strategic guidance through each stage of growth from Seed through to potential public listing or acquisition. The firm's exclusive focus on B2B SaaS and its substantial presence in the ANZ market gives it deep pattern recognition and a strong network of enterprise buyer relationships that can meaningfully accelerate portfolio company sales cycles and market positioning.

Ewo Capital is a private equity and venture capital firm that focuses on providing growth capital to businesses in sectors like technology, healthcare, and consumer goods. Although specific details about their portfolio and investment strategy are not fully public, Ewo Capital typically looks for high-growth companies that are scaling in competitive markets. They are involved in later-stage investments, providing not only financial backing but also strategic guidance and operational support to help companies expand. Ewo Capital’s approach centers on creating value through long-term partnerships, leveraging both industry expertise and a global network to drive business growth. If you're a company with significant traction, looking for capital to fuel the next stage of growth, Ewo Capital could be a valuable partner. For entrepreneurs and companies, Ewo Capital's experience in scaling businesses and navigating complex industries could offer both financial and strategic benefits. If you’re considering contacting them, ensure your venture is well-positioned for rapid growth and has a clear market opportunity.

Excalibur Capital, based in Washington, DC, is a prominent investment banking firm specializing in middle-market mergers and acquisitions, capital raising, and financial advisory services. Their engagements typically range from $50 million to $1 billion, covering a wide array of industry sectors and geographies. Excalibur has a strong track record of facilitating significant transactions, such as the partnership between Salas O’Brien and Crossey Engineering, as well as the equity investment by Long Point Capital in Allnorth Consultants Limited. These deals underscore Excalibur's expertise in engineering and technical services, showcasing their ability to drive growth and strategic expansion for their clients. The firm operates with a commitment to fostering long-term relationships with shareholders, emphasizing company culture, leadership, and legacy alongside financial performance. Managed by Edward Novicky, Excalibur prides itself on delivering tailored solutions that align with the unique goals of each client, ensuring both strategic and cultural fit. For startups and businesses looking to engage with Excalibur Capital, a clear and compelling presentation of growth potential, strategic fit, and alignment with the firm's values is essential. They prefer direct, well-structured proposals that highlight the innovative and impactful aspects of the business. Excalibur's involvement often includes leading investment rounds and providing ongoing strategic support to ensure the sustained success and growth of their portfolio companies.

Excalibur Group Holdings, based in London, is a venture capital firm with a strong focus on life sciences, biotechnology, and medical devices. Established in 1996, the firm has built a reputation for bridging the gap between research and commercialization, providing both early and late-stage capital. Excalibur plays an active role in developing cutting-edge therapies, diagnostics, and healthcare technologies. Their investment strategy targets companies that are innovating in critical areas such as oncology, therapeutic devices, and laboratory services. The firm has made over 59 investments, with notable companies like Celsis International, NeoGen, and Selah Genomics. Excalibur's investments span various stages, from early ventures to generating revenue, and their portfolio emphasizes transformative healthcare solutions. They have also facilitated numerous successful exits, including companies like Plethora Solutions and Celsis In Vitro. Excalibur's approach is highly strategic, supporting startups not just with capital but also by offering market access and strategic advice, positioning them for acquisitions or public listings. This makes Excalibur a critical player in the European life sciences venture space, known for its ability to take healthcare innovations from the lab to the marketplace.

Excel Venture Management, founded in 2007 and headquartered in Boston, Massachusetts, specializes in investing in transformative life science technologies. The firm’s portfolio spans healthcare IT, diagnostics, medical devices, and life science platforms, addressing a broad array of industries including agriculture, energy, and defense. Notable investments include InfoBionic, Aileron Therapeutics, and Molecular Templates. Excel's strategy focuses on early to late-stage investments, typically ranging from $1 million to $5 million. They avoid single-molecule drugs, preferring platform technologies that offer multiple exit scenarios and applications across diverse market sectors. The firm's holistic approach involves extensive due diligence, strategic guidance, and leveraging a global network of resources to drive portfolio companies towards leadership positions in their fields. The team, led by key figures like Jeanne Henry (CFO) and Juan Enriquez (Managing Director), brings a wealth of experience in venture capital, financial management, and life sciences. They work closely with entrepreneurs to refine corporate strategies, develop value-driven milestones, and facilitate customer and partner introductions, ultimately aiming for successful exits through acquisitions or IPOs. Excel Venture Management has been instrumental in the success of companies like ClearDATA, Cleveland HeartLab, and Synthetic Genomics, showcasing their commitment to driving innovation in the life sciences sector and beyond​.

Excell Partners is a prominent venture capital firm based in Rochester, New York. Established in 2006, it focuses on seed-stage investments, primarily targeting high-tech, high-growth startups in Upstate New York. Excell Partners is an affiliate of the University of Rochester and manages over $40 million in assets, having invested in 60 companies across various sectors including medical devices, materials, energy, biotech, agtech, imaging, and IT/software. Under the leadership of CEO Theresa Mazzullo, Excell Partners emphasizes a hands-on approach, providing not only capital but also extensive support through strategic guidance, a broad network of professionals, and long-term partnership commitments. Their investment strategy includes maintaining "dry powder" for follow-on funding to ensure continuous support for portfolio companies as they scale. Excell Partners also manages the $25 million Finger Lakes Forward Venture Capital Fund, which supports regional strengths in optics, imaging, photonics, food and agriculture, life sciences, and advanced manufacturing. This fund aims to boost economic growth in the Greater Rochester area by increasing access to capital for high-tech startups. Notable investments include RealEats, a prepared meal delivery service, and Owl Autonomous Imaging, which focuses on advanced thermal sensor technologies. Excell Partners is dedicated to fostering innovation and economic development in the Finger Lakes region, leveraging the area's academic and research strengths to nurture promising startups and retain local talent.

Exceptional Capital, founded in 2022 by Marell Evans, is a venture capital firm that specializes in backing disruptive early-stage companies, particularly within the B2B enterprise software and cybersecurity sectors. Based in New York, the firm actively seeks out startups at the pre-seed and seed stages, providing more than just financial backing. Exceptional Capital prides itself on becoming a strategic partner to founders, offering deep operational expertise, ongoing mentorship, and a strong commitment to helping companies navigate the challenges of scaling. What sets Exceptional Capital apart is its hands-on approach. Marell Evans and his team are known for their relentless dedication to the success of their portfolio companies. They engage closely with founders, providing not only capital but also strategic insights to propel companies toward long-term market leadership. For instance, Lumu, a global leader in continuous compromise assessment, has benefited significantly from Exceptional Capital’s involvement, gaining both strategic support and operational guidance to expand its footprint. Similarly, Coactive, a company focused on AI-powered analytics, exemplifies the type of high-growth potential that Exceptional Capital looks for in its investments. Their strategy centers on identifying companies with strong disruptive potential and supporting them from early stages to eventual market dominance. With a focus on innovation and a deep network of industry experts, Exceptional Capital has quickly become a go-to partner for founders looking to scale rapidly in highly competitive markets.

Exceptional Ventures is a London-based venture capital firm focused on investing in high-impact startups that aim to improve health, happiness, and longevity while also supporting a sustainable planetary ecosystem. Founded by Matt Cooper and Paolo Pio, the firm manages its debut fund, EV Fund 1, which is a £20 million fund designed to build a portfolio of 40 early-stage startups primarily across the UK and Europe, with some investments globally. The firm invests primarily in three sectors: HealthTech, FoodTech, and Financial Wellbeing. Their strategy is to back startups at the pre-seed and seed stages, with the potential to follow on with additional funding as these companies grow and approach Series A. Exceptional Ventures' portfolio is expected to span a variety of innovative companies within these sectors, supporting technological advancements that contribute to a healthier and more sustainable future. The founders bring extensive experience in venture capital and entrepreneurship. Matt Cooper co-founded Capital One Bank and has chaired Octopus Group, while Paolo Pio has a strong background in tech and venture capital, having previously led Joyance Partners in Europe.

Exfinity Venture Partners is an early-stage venture capital firm founded in 2013 in Bengaluru, India, focused exclusively on backing B2B technology companies built from India for global markets. The firm was promoted by four veterans of the Indian IT industry: Mohandas Pai and V Balakrishnan, both former CFOs of Infosys; Girish Paranjpe, former CEO of Wipro; and Deepak Ghaisas, former CEO of iflex. With a portfolio of more than 40 companies, Exfinity has backed founders across AI and machine learning, cybersecurity, autonomous robotics, AI cancer diagnostics, EV and mobility, computer vision, IoT, big data and analytics, and cloud computing. The firm leads rounds and deploys initial checks typically between $500K and $3 million, with maximum deal sizes reaching $5 million, investing primarily at Seed and Series A stages. The portfolio includes one unicorn, Cult.fit, and seven acquisitions including Locus and Ai Palette. Exfinity targets founders who are building disruptive, innovative technology products with a clear global ambition rooted in India. Exfinity differentiates itself through a world-class mentorship ecosystem built from the operational credibility of its founding team. The promoters bring direct experience scaling multi-billion-dollar IT enterprises and leverage those networks to help portfolio companies navigate enterprise sales, international expansion, and follow-on fundraising. The firm is deeply committed to the Indian B2B deep tech thesis, treating mentorship and financial capital as equally important inputs for company building.

Exitfund Ventures is a venture capital firm founded in 2010 and based in San Francisco, California, investing in early-stage enterprises with the potential to transform the global economy. The firm is deliberately stage-, sector-, and geography-agnostic, concentrating primarily on pre-seed, seed, and Series A rounds, with a focus on the highest-conviction founders regardless of domain. Exitfund has made 11 investments to date, with portfolio companies spanning software, AI, SaaS, and fintech across the United States and India. The firm writes checks in the range of $100K to $2 million and operates with a team of 19 professionals including 1 Partner, 12 Venture Partners, and 1 Principal across India and the US. Beyond capital, Exitfund delivers founder introductions, recruiting support, go-to-market counsel, and hands-on operational expertise designed to accelerate product-market fit and early-stage scaling. The firm also maintains an AngelList syndicate to facilitate co-investment opportunities. Exitfund's investment philosophy centers on backing the highest-impact founders it can find, prioritizing the quality of the individual over any particular sector or geography. The team believes that exceptional founders with clarity of purpose are the most reliable signal for long-term value creation, and structures its support accordingly.

Exor N.V. is a prominent European investment company headquartered in Amsterdam, Netherlands, controlled by the Agnelli family. Established in 1927, Exor's portfolio is diverse, encompassing various industries such as automotive, luxury goods, media, and healthcare. Key holdings include significant stakes in well-known companies such as Ferrari, Stellantis, and CNH Industrial. Exor owns 22.9% of Ferrari, making it a crucial player in the luxury sports car market. Stellantis, one of the world's leading automakers, also forms a significant part of their portfolio with brands like Fiat, Chrysler, and Peugeot. CNH Industrial, involved in agricultural and construction equipment, is another major investment. In the media sector, Exor holds a substantial share in The Economist Group, owning 43.4% of its economic rights. They also have a significant investment in GEDI Gruppo Editoriale, a major Italian media conglomerate, holding 89.6% of the economic rights. Exor's investment strategy focuses on long-term value creation, often involving active participation in the management of their portfolio companies to drive growth and innovation. This approach is evident in their diversified and strategically selected investments across various sectors.

Expa, founded by Garrett Camp in 2013, is a venture studio and VC fund based in San Francisco. It focuses on early-stage investments, particularly in SaaS, FinTech, ClimateTech, E-Commerce, and software sectors. Notable investments include companies like Aero, Current, Collective, Metabase, and Joro. With over 100 investments and 11 exits, Expa typically provides seed funding between $500K and $1M and plays an active role in guiding startups through MVP development, hiring, and finding product-market fit. Expa’s strategy is centered around supporting founders with both capital and hands-on expertise. They value strong, innovative ideas and prefer to be approached with detailed, well-structured pitches demonstrating clear market potential. Their global reach includes significant investments across the U.S., with key operations in San Francisco​​. The Expa team, featuring industry leaders and experienced entrepreneurs, ensures robust support for their portfolio companies. For those looking to engage with Expa, networking through industry events and leveraging mutual connections can be effective ways to gain their attention.

Expanding Capital (XCap) is a venture capital firm based in Burlingame, California, that focuses on investing in early-stage technology companies. The firm’s investment strategy centers on providing capital and support to startups in sectors such as artificial intelligence, financial technology, healthcare, and robotics. XCap works closely with founders, offering not just funding but also access to networks and resources, ensuring long-term growth and sustainability for the businesses they back. The firm typically invests in Series A and Series B rounds, with check sizes ranging from $500,000 to $5 million. Their portfolio includes companies like Kernalbio, Postscript, and Raydiant, which are involved in drug discovery and productivity software. Expanding Capital has successfully led exits in companies like Coinbase and ClassPass, cementing its position as a key player in the tech VC space. For entrepreneurs looking to partner with XCap, the firm offers a long-term view on investments, helping businesses scale and unlock their full potential. They prioritize innovation-driven companies that are positioned for rapid growth.

Expansion Venture Capital, also known as Expansion VC, is a prominent early-stage venture capital firm focused on investing in pre-seed, seed, and select Series A stage technology companies. Founded by brothers Joseph and Ryan Melohn, the firm operates primarily out of New York City and Miami. Expansion VC's portfolio boasts a range of successful companies across various sectors, including notable investments in ClassPass, Turo, Carta, Lemonade, The RealReal, Allbirds, and Firebase. These investments span industries such as fintech, proptech, digital health, and consumer technology. The firm is known for its hands-on approach, providing not just capital but also strategic support in areas like mentorship, customer acquisition, talent sourcing, and securing partnerships. The firm prides itself on building long-term relationships with its founders, offering around-the-clock support to help navigate challenges and drive growth. Expansion VC has a reputation for leveraging its extensive network to accelerate the success of its portfolio companies by facilitating key introductions and securing strategic guidance.

Expara IDM Ventures is Singapore's longest-established early-stage venture capital and venture services firm, founded in 2003 by Douglas Abrams, who has been investing in Singapore's startup ecosystem since 2000. Operating as the incubator fund arm of Expara, the firm has built an integrated platform spanning acceleration, incubation, entrepreneurship training, mentorship, and advisory services for the broader enterprise ecosystem across Southeast Asia. With 58 investments across the region, Expara is the pioneer in full-spectrum early-stage venture support in Southeast Asia. The firm leads rounds and writes checks typically between $100K and $1 million, focusing on pre-seed and seed stages. Its portfolio spans software and apps, e-commerce and retail, AI, SaaS, fintech, healthtech, education, and media, with the heaviest concentration in Singapore (9 companies) and Thailand (5 companies). A fund raise of $21.6 million was underway to extend the firm's investment capacity across the region. Expara's approach is distinct in combining capital deployment with institutional capacity-building infrastructure. Rather than investing at arm's length, the firm embeds itself in the founder's journey through its incubation and acceleration programs, ensuring portfolio companies benefit from curated mentorship networks, operational coaching, and the firm's two decades of Southeast Asian market knowledge. This full-service model has made Expara a foundational institution in the regional startup ecosystem.

Expedite Ventures is a Berlin-based business angel group founded in 2020, composed of active and former CTOs and CPOs who invest their own capital in early-stage technology founders. The group backs pre-seed and seed stage startups, writing checks between $100K and $500K, with occasional participation at Series A. Expedite has made 11 investments spanning SaaS, software, AI, fintech, and healthtech, with a geographic focus on Germany and the United States. The firm's core thesis centers on software categories that drive creation and transformation, including SaaS, developer tools, and productivity tools. Members are described as nerds at heart, with several partners still actively running their own startups while investing. This practical orientation shapes how Expedite engages with portfolio companies: support is hands-on and technically grounded, covering product architecture, team building, and go-to-market alongside capital. Expedite specifically welcomes first-time founders and does not filter by gender or background, prioritizing intellectual rigor and product conviction over pedigree. The group's structure as an angel collective means each member brings direct operational context from running technology businesses, giving portfolio companies access to a bench of seasoned product and engineering leaders who understand the challenges of early-stage company building from the inside.

Experian Ventures is the corporate venture capital arm of Experian, the world's leading global information services company, founded in 2016 and headquartered in Silicon Valley with offices in London, Singapore, Costa Mesa, and Sao Paulo. The firm invests on the premise that disruption in a data and technology-driven world depends on the creative forces of entrepreneurs. With 51 investments to date, Experian Ventures backs startups delivering solutions that simplify credit and lending, reduce complexity in specialized verticals, automate and secure workflows, and improve consumers' financial lives. The firm targets Series A and Series B rounds, writing checks between $1 million and $10 million. Portfolio companies include Sardine, a fraud prevention platform that raised a Series C in February 2025; Array US, a financial data platform; Passport; and KYXStart. Investments span fintech, AI, security, data analytics, healthcare, automotive, blockchain, and IoT, reflecting Experian's core belief that new value is created through data and technology across a wide range of verticals. As a strategic corporate investor, Experian Ventures provides portfolio companies with more than capital. The firm leverages Experian's global distribution, enterprise relationships, and proprietary data assets to help startups accelerate commercial traction. Portfolio companies benefit from access to Experian's operational infrastructure and industry credibility, particularly those whose solutions touch credit, identity, and financial data workflows.

Expert Dojo is an early-stage startup accelerator and venture capital firm based in Santa Monica, California. Since its founding in 2018, Expert Dojo has invested in over 260 startups worldwide, focusing primarily on pre-seed and seed-stage companies. They offer $50,000 for a 3.5% equity stake, and their portfolio consists largely of minority and female-led startups across various industries, including technology, healthcare, and e-commerce. Their investment approach goes beyond funding, as they provide a comprehensive growth program aimed at accelerating startups' success. This program includes personal sales coaching, branding optimization, and extensive outreach strategies. Expert Dojo also holds quarterly demo days to showcase startups to potential investors and offers up to $1 million in follow-on investments for top-performing companies. The firm is particularly well-known for its emphasis on diversity, with 41% of its portfolio companies being female-founded. Expert Dojo is a great partner for early-stage founders looking for hands-on support to scale rapidly and navigate the challenges of reaching Series A funding.

Explorer 1 Fund is a specialized venture capital firm based in Venice, California, dedicated to investing in the rapidly expanding space economy. Founded in 2021, the firm focuses on companies that are fundamental to the growth and success of space-related industries. Explorer 1 Fund targets a wide range of sectors within the space economy, including satellite technology, space exploration, and related technologies that support this frontier. The team at Explorer 1 Fund brings together an impressive array of expertise, including over 32 years of experience at NASA's Jet Propulsion Laboratory (JPL), 10 years in aerospace engineering at industry giants like Boeing and Blue Origin, and over 20 years of institutional investing experience in early-stage ventures and public equities. This deep knowledge base allows the firm to make informed, strategic investments that are aligned with the latest advancements in space technology. Explorer 1 Fund typically invests in early-stage companies, particularly those at the Seed and Series A stages. The firm is known for its hands-on approach, providing not just capital but also strategic guidance and access to a broad network of industry leaders and experts. Their investment portfolio includes cutting-edge companies like Space Perspective and Lunar Outpost, which are leading innovations in space tourism and lunar technology, respectively. With a mission to drive the next generation of space exploration and technology, Explorer 1 Fund is well-positioned to shape the future of this exciting and transformative industry​.

Expon Capital, founded in 2015 and based in Luxembourg, is a prominent venture capital firm dedicated to investing in early-stage technology startups. Their investment focus spans a wide array of sectors including cybersecurity, fintech, regtech, big data, digital health, digital learning, IoT, next-generation media, and communication networks. Expon Capital is particularly noted for backing companies with a high potential for meaningful impact through digital and deep tech innovations. The firm manages both seed and growth funds, providing significant support to startups from the initial stages through to scaling. Notable investments include companies like Glovo, Spire, and WeFarm, highlighting Expon’s ability to identify and nurture high-growth potential ventures. Expon Capital’s team is led by experienced industry veterans such as Jérôme Wittamer, Alain Rodermann, and Marc Gendebien. Wittamer, who has a background in technology and telecom, is responsible for sourcing opportunities across Europe and Israel. Rodermann brings extensive experience from his tenure at Innovacom and Sofinnova Partners, focusing on AI-driven consumer and business services, as well as space technologies. Gendebien adds his financial management expertise, particularly in public and private equities. Expon Capital emphasizes strong connections and hands-on support, leveraging a global network of tech entrepreneurs, digital executives, and corporate partners to drive the success of their portfolio companies.

Exponent Founders Capital, based in New York City, is a $125 million early-stage fund specializing in software and fintech. The fund focuses on supporting founders from the earliest stages through IPO and beyond, with investments ranging from $0.5 to $5 million. Exponent’s portfolio includes notable startups like Plaid, Ramp, Robinhood, Alloy, Chronosphere, and Stytch. Led by Charley Ma and Mahdi Raza, both experienced in scaling startups from zero to substantial revenue, Exponent emphasizes a thematic market and customer-driven investment approach. They prioritize founders with deep experience in transformative markets, investing across verticals such as AI, fintech, payments, infrastructure, security, and application software. Their geographic focus spans the US, Europe, and Canada. Exponent is known for its hands-on support, leveraging a robust network to aid in design, hiring, and strategy. They are backed by non-profit endowments, hospitals, and over 50 unicorn founders and operators, reflecting a strong commitment to both financial returns and social impact.

Exponential Impact is an accelerator and incubator focused on early-stage companies in Colorado. Based in Colorado Springs, Exponential Impact supports startups through funding, mentorship, and a robust network aimed at driving economic development and innovation in the region. The organization provides a variety of programs tailored to different stages of a startup's journey, from initial idea validation to scaling operations​. Their portfolio includes companies across diverse sectors, particularly those leveraging technology to create significant social and economic impact. The firm emphasizes the importance of digital assets and distributed ledger technology in fostering inclusive economic growth​​. For startups looking to engage with Exponential Impact, demonstrating a clear mission to expand human potential and alleviate suffering through innovative solutions can be advantageous. Their integrated support model, which includes advisory, capital raising, and access to market services, provides a comprehensive framework to help startups thrive​.

ExSight Ventures is a New York City-based life sciences venture capital firm founded in 2014, specializing exclusively in early-stage ophthalmic diagnostic and treatment solutions. The firm was co-founded by James Murray alongside Dr. Michael Nissen, a retinal surgeon on faculty at Weill-Cornell Medical Center since 1998, and Dr. Firas Rahhal, also a retinal surgeon. The team of eight partners combines deep clinical domain expertise with investment and legal experience, including Murray's role as Chair of the Emerging Companies and VC Committee at the NYC Bar Association. ExSight raised its fourth fund in 2025, marking continuous growth since founding. The firm leads rounds and deploys checks from $250K to $4 million, investing from Seed through Series B in companies across North America. With 21 investments to date, notable portfolio companies include Horizon Surgical Systems, for which ExSight led a $30 million Series A in October 2024 in a robotics and AI surgical platform; ONL Therapeutics, which raised $65 million in a Series D alongside J&J Innovation; Re-Vana Therapeutics; Envision Diagnostics; Trefoil Therapeutics; LensGen; and Valitor Bio. Three portfolio companies have been acquired: DTx Pharma by Novartis, RetroSense Therapeutics by Allergan, and ELIOS Vision by Bausch & Lomb in December 2024. ExSight's thesis holds that ophthalmology is an ideal venture investment domain due to its massive and growing global market, insufficient current standards of care, a robust innovation pipeline, and the eye's unique anatomy as a proving ground for breakthrough technologies including gene therapy, AI diagnostics, and surgical robotics. The firm's clinical founders give it a differentiated vantage point for evaluating scientific merit, clinical feasibility, and commercial potential simultaneously.

Extantia Capital is a Berlin-based venture capital firm dedicated to accelerating decarbonization through early-stage investments in climate technology. With over €100 million in assets under management, Extantia focuses on scalable deep decarbonization solutions that have the potential to significantly reduce global carbon emissions. The firm employs a "carbon math exclusion principle," investing only in startups that can abate at least 100 million tonnes of CO2 annually when fully scaled. This strategy directs them towards hardware-based innovations in sectors such as energy, carbon removal, transportation, and industrial processes. Extantia operates through two main funds: Flagship, which backs transformative companies like INERATEC (e-fuels) and Reverion (biogas energy), and Allstars, which invests in other climate-focused venture funds. Their portfolio includes 12 companies, many of which focus on hard-to-abate sectors using technologies like direct air capture and green hydrogen production. The firm’s approach to building successful ventures is deeply rooted in strong founding teams, balancing technical expertise with commercial acumen. Extantia looks for co-founders who can work collaboratively across disciplines, ensuring that both the technological and business aspects of their startups are well-aligned. Looking forward, Extantia anticipates that the next generation of unicorns will emerge from the climate tech space. They are particularly excited about trends like green ammonia and the sustainable mining of raw materials, which are critical for the energy transition. Extantia is positioning itself at the forefront of this shift, creating opportunities for both significant climate impact and financial return.

Extreme Venture Partners (EVP) is a venture capital firm based in Canada that focuses on seed-stage B2B software startups. With over 100 investments and three funds, they have helped create over 10,000 jobs and generated billions in shareholder value. Their portfolio includes notable startups like SideDrawer and Foxquilt, with exits to major global brands. EVP invests primarily in companies with a global market focus, emphasizing those that show strong early traction but are post-revenue. The firm's strategy is highly concentrated, typically investing in up to 15 companies per fund. EVP does not invest pre-revenue but partners early with founders, aiming to mentor and scale businesses that disrupt traditional industries. They primarily operate in the software sector, especially in SaaS and cloud-based solutions. With over $270 million in assets under management, they are key players in Canada’s tech ecosystem, but their portfolio also spans Australia and New Zealand, demonstrating their geographic breadth. Co-founder Howard Leibman emphasizes EVP's consistency and its unique advantage in focusing exclusively on early-stage B2B software, which has resonated with their investors. This niche focus, coupled with a strong network of family offices and high-net-worth individuals, sets EVP apart in the competitive venture capital landscape. Their commitment to being hands-on partners makes them an attractive option for founders looking to scale globally.